<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03098303</url>
  </required_header>
  <id_info>
    <org_study_id>9373</org_study_id>
    <secondary_id>2014-A01201-46</secondary_id>
    <nct_id>NCT03098303</nct_id>
  </id_info>
  <brief_title>Criteria Associated With Patient Willingness to Participate in Biomedical Research</brief_title>
  <acronym>PROTOACCEPT</acronym>
  <official_title>Criteria Associated With Patient Willingness to Participate in Biomedical Research: a Prospective, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the variables associated with patient&#xD;
      acceptation or refusal to participate in a clinical research protocol when seen in during a&#xD;
      pneumology consultation (excluding oncology and tobaccology).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are:&#xD;
&#xD;
        -  To compare patient acceptance rates for participation in a clinical research protocol&#xD;
           before and after January 15, 2016.&#xD;
&#xD;
        -  To determine the variables associated with accepting or refusing to participate in a&#xD;
           clinical research protocol for patients seen during a pneumology consultation (excluding&#xD;
           oncology and tobaccology) before January 15, 2016.&#xD;
&#xD;
        -  To determine the variables associated with accepting or refusing to participate in a&#xD;
           clinical research protocol for patients seen during a pneumology consultation (excluding&#xD;
           oncology and tobaccology) after January 15, 2016.&#xD;
&#xD;
        -  To describe the patient population seen during pneumology consultations.&#xD;
&#xD;
        -  To determine the variables associated with accepting or refusing to participate in a&#xD;
           clinical research protocol sponsored by a pharmaceutical laboratory.&#xD;
&#xD;
        -  To determine the variables associated with accepting or refusing to participate in a&#xD;
           clinical research protocol sponsored by an academic institution.&#xD;
&#xD;
        -  Construct clusters (homogeneous groups) of patients seen during the pneumology&#xD;
           consultations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 23, 2014</start_date>
  <completion_date type="Actual">December 13, 2016</completion_date>
  <primary_completion_date type="Actual">December 13, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptation or refusal to participate in a biomedical research study</measure>
    <time_frame>Day 0 (cross-sectional study)</time_frame>
    <description>Positive or negative response to the question &quot;If a biomedical research protocole were proposed to you, would you accept to participate?&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The PROTOACCEPT questionnaire</measure>
    <time_frame>Day 0 (cross-sectional study)</time_frame>
    <description>The PROTOACCEPT questionnaire (see links below).</description>
  </secondary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Consulting in Pneumology Department, But Not for Oncology or Tobacology</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The target population corresponds to patients with respiratory disease. This study will be&#xD;
        proposed to all patients consulting (excluding oncology and tobacco) in the associated&#xD;
        departments.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient was informed about the study.&#xD;
&#xD;
          -  The patient is scheduled for a consult in the pneumology department&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is under judicial protection or is an adult under any kind of guardianship&#xD;
&#xD;
          -  The patient expresses opposition to the study&#xD;
&#xD;
          -  It is impossible to correctly inform the patient about the study&#xD;
&#xD;
          -  The patient cannot fluently read French&#xD;
&#xD;
          -  The patient is pregnant&#xD;
&#xD;
          -  The patient is breastfeeding&#xD;
&#xD;
          -  The patient has cancer&#xD;
&#xD;
          -  The patient is consulting in tabaccology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Bourdin, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Montpellier University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Polyclinique Saint-Privat</name>
      <address>
        <city>Boujan-sur-Libron</city>
        <zip>34760</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de Marignane</name>
      <address>
        <city>Marignane</city>
        <zip>13700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - HÃ´pital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://osf.io/gccjd/</url>
    <description>The PROTOACCEPT patient questionnaire</description>
  </link>
  <link>
    <url>https://osf.io/nsjjr/</url>
    <description>PROTOACCEPT on the Open Science Framework</description>
  </link>
  <results_reference>
    <citation>Pahus L, Suehs CM, Halimi L, Bourdin A, Chanez P, Jaffuel D, Marciano J, Gamez AS, Vachier I, Molinari N. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials? BMC Med Ethics. 2020 Aug 13;21(1):72. doi: 10.1186/s12910-020-00509-y.</citation>
    <PMID>32791969</PMID>
  </results_reference>
  <results_reference>
    <citation>Molinari N, Suehs C, Vachier I, Pahus L, Halimi L, Gamez AS, Chanez P, Bourdin A. Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials. Clin Trials. 2019 Aug;16(4):440-442. doi: 10.1177/1740774519840268. Epub 2019 Mar 29.</citation>
    <PMID>30922104</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>March 27, 2017</study_first_submitted>
  <study_first_submitted_qc>March 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2017</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

